04/16/2024
4:00 PM | Connect Biopharma (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
04/16/2024
3:20 PM | Connect Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/27/2024
8:00 PM | Connect Biopharma (Subject)
Panacea Innovation Ltd (Filed by)
| Form SC 13D/A | |
02/13/2024
3:18 PM | Connect Biopharma (Subject)
Wei Zheng (Filed by)
| Form SC 13G/A | |
12/20/2023
3:30 PM | Connect Biopharma (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
12/18/2023
5:44 PM | Connect Biopharma (Subject)
RA Capital Nexus Fund, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023
5:09 PM | Connect Biopharma (Subject)
RA Capital Healthcare Fund LP (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023
3:30 PM | Connect Biopharma (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
12/12/2023
6:40 PM | Connect Biopharma (Subject)
RA Capital Nexus Fund, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
6:05 PM | Connect Biopharma (Subject)
RA Capital Healthcare Fund LP (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
5:10 AM | Connect Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/04/2023
4:20 PM | Connect Biopharma (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
11/27/2023
6:32 PM | Connect Biopharma (Subject)
RA Capital Healthcare Fund LP (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2023
6:49 PM | Connect Biopharma (Subject)
RA Capital Nexus Fund, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023
5:58 PM | Connect Biopharma (Subject)
RA Capital Healthcare Fund LP (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023
6:09 PM | Connect Biopharma (Subject)
RA Capital Nexus Fund, L.P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023
5:13 AM | Connect Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/20/2023
3:44 PM | Connect Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/04/2023
4:26 PM | Connect Biopharma (Subject)
Huang James (Filed by)
| Form SC 13G/A | |
09/12/2023
3:47 PM | Connect Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/12/2023
5:13 AM | Connect Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/14/2023
4:00 PM | Connect Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/23/2023
3:31 PM | Connect Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/01/2023
3:24 PM | Connect Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
